| Condition | Country | Study population | Evidence of association | Observation |
| Acute myocardial infarction | USA [34] | 2,343 | Lack of association | Demonstrating a lack of significant association in type 2 diabetic patients only. | Netherlands, Spain, and UK [42] | 17.7 million | Weak | Significant association after adjustment for age and smoking. However, the significance was lost after adjusting for systolic blood pressure, type 2 diabetes, total cholesterol level, statin use, and hypertension. | Turkey [38] | 224 | Strong | NAFLD was more frequent in MI patients. | Korea [43] | 3,011,588 | Strong | FLI significantly associated with MI even after performing stratified analyses by body weight, cholesterol, age, sex, use of dyslipidemia medication, obesity, diabetes, and hypertension. | Germany [44] | 44,096 | Strong | Significant association even after performing regression analysis. | Korea [46] | 111,492 | Strong | Significant association even after performing adjustments for age, sex, year of visit, smoking status, alcohol intake, BMI, systolic blood pressure, fasting glucose, LDL cholesterol, use of antihypertensive medications, use of antidiabetic medications, use of lipid-lowering medications, and use of aspirin and antithrombotic medications at baseline. | USA [47] | 13,290 | Strong | NAFLD subtypes 2 and 5 were independently significantly associated with MI. |
| STEMI | Finland [41] | 1,205 | Weak | FLI is associated with MI in minimally adjusted models. However, it lost significance in most comprehensive models with metabolic factors. | Italy [33] | 95 | Strong | High prevalence of NAFLD in nondiabetic patients admitted for STEMI. | Turkey [36] | 186 | Strong | Severe FLD is an independent predictor of STEMI by performing multivariate analysis. |
| ACS | Canada [45] | 139 | Strong | 60.5% of severe CAD patients had NAFLD. |
|
|